Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMOTIVE retrospective study of vedolizumab in inflammatory bowel disease with extraintestinal manifestations
MOH_2018-07-24_003539Phase 4Active, not recruiting
- Sponsor
- Takeda
- Start
- Jun 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vedolizumab in autoimmune colitis and Crohn's disease, sponsored by Takeda. Started Jun 2018; status: active, not recruiting.
02
Drugs
vedolizumab
03
Conditions
autoimmune colitisCrohn's disease
Beyond the preview
Go deeper on MOH_2018-07-24_003539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-07-24_003539.